
Mihail G. Chelu, MD, PhD
@mihailchelu
Physician-scientist | Professor | Director EP & Clinical EP Research - @BCMHouston co-PI with @KennethEllenbo1 of @leftvsleft RCT
ID: 4130567653
05-11-2015 02:54:32
1,1K Tweet
1,1K Takipçi
263 Takip Edilen

Novel mapping data and a new proposed strategy for RBBB patients and CRT/CSP Roderick Tung #PPS8 #epppeps University of Arizona



Phoenix will be the host city for #PPS9in 2025. 🌄 UAZ Medicine - Phoenix Please DM any suggestions for next year!


@BCMHouston and The Texas Heart Institute have signed an agreement to form a premier cardiovascular health and research center, uniting two of the nation's most distinguished programs in cardiovascular medicine. Read the announcement: texasheart.org/the-texas-hear…

Pull up for a long thread about this Vox article with the subtitle "What the fight between Anthem Blue Cross and Blue Shield and anesthesiologists was really about." 1/12 🧵 Anesthesiology News vox.com/policy/390031/…

Milestone: We randomized 10% of the LeftvsLeft RCT study participants. Grateful to our patient partners, investigators, and stakeholders for their support! Mihail G. Chelu, MD, PhD Kenneth Ellenbogen The Patient-Centered Outcomes Research Institute

Join us for the Ali Massumi Cardiac Arrhythmia Symposium: texasheart.org/massumi25 • 1-day hybrid event • Exploring arrhythmia management. • Attend in person or virtually Mohammad Saeed Mihail G. Chelu, MD, PhD abdi rasekh



CSP vs. RVP, results of randomized trial, and UHF-ECG vs. low-frequency ECG to discriminate trueLBBB from IVCD. I am looking forward to meeting you in San Diego. Marek Jastrzębski Zachary Whinnett Kevin Vernooy Margarida Pujol Lopez Mihail G. Chelu, MD, PhD Roderick Tung


One week to go! Register for the Ali Massumi Cardiac Arrhythmia Symposium happening next Saturday at InterContinental Houston. Join us to improve the quality of care for patients with arrhythmias: texasheart.org/massumi25 Course Directors: Mohammad Saeed Mihail G. Chelu, MD, PhD abdi rasekh

Significantly less acute brain emboli among left ventricular catheter ablation patients randomized to a transseptal versus a retrograde aortic approach per our The Patient-Centered Outcomes Research Institute-funded #TRAVERSE trial. Thank you to our patients who helped design and implement the study, my generous EP

William Dillon, M.D. @ed_gerst Roderick Tung Jonathan Hsu, MD Mihail G. Chelu, MD, PhD ZoEP @EhdaieMD Babak Nazer Joshua Moss MD @tjaredbunch Andrew Beaser @boatnoodlesoup Alexios Hadjis Greg Marcus


NEW from Heart Rhythm TV: #HRStv host JC ZERPA is joined by Kenneth Ellenbogen and Mihail G. Chelu, MD, PhD to discuss the Left vs Left Trial. See the full interview here #EPeeps ➡️ bit.ly/4iKO5lu

#ICYMI: The TRAVERSE Trial #AHAJournals William Dillon, M.D. @ed_gerst Roderick Tung Jonathan Hsu, MD Mihail G. Chelu, MD, PhD @Zo_EP @EhdaieMD Babak Nazer Joshua Moss MD @tjaredbunch Andrew Beaser Alexios Hadjis


Immediately following the #LBCT presentation at #HRS2025, Heart Rhythm TV host Nashwa Abdulsalam sat down with Pugal Vijayaraman to discuss Left Bundle Branch Area Pacing Compared To Biventricular Pacing in Candidates for Cardiac Resynchronization Therapy (LVEF <50%): Results From

Hierarchical Physiologic Pacing to Enhance Clinical Outcomes in Conduction System Pacing #HRS2025 #LBCT Shunmuga Sundaram Ponnusamy heartrhythmjournal.com/article/S1547-…

Our new Madam President, Dr. Mina Chung to lead Heart Rhythm Society! 🎊 Incredible and tireless leadership from Dr. Ellenbogen, thank you for a great year. 🙏
